{"id":"W3088760968","doi":"10.1016/j.annonc.2020.08.2312","title":"LBA71 Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Foundation Medicine; Merck Sharp and Dohme; EMD Serono; Genentech; NeraCare; Bavarian Nordic; Eisai; Puma Biotechnology; Mirati Therapeutics; Clovis Oncology; Eli Lilly and Company; National Comprehensive Cancer Network; Les Laboratories Pierre Fabre; Heron Therapeutics; TG Therapeutics; Celldex Therapeutics; Regeneron Pharmaceuticals; Pfizer; Incyte; F. Hoffmann-La Roche; PharmaMar; Alexion Pharmaceuticals; Bristol-Myers Squibb; Invitae; AstraZeneca; American Society of Clinical Oncology; Daiichi Sankyo Europe; Servier; Gilead Sciences; PTC Therapeutics; Exelixis; Sanofi; Ipsen; Array BioPharma; Spectrum Pharmaceuticals; Amgen","keywords":"Medicine; Chemoimmunotherapy; Internal medicine; Cancer; Asymptomatic; Cancer registry; Cohort; Chemotherapy; Incidence (geometry); Surgery; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001570947,0.0003397676,0.0006990156,0.002245691,0.000691166,0.001506994,0.0006286839,0.0005285307,0.003154035],"category_scores_gemma":[0.004873852,0.0004385256,0.001367621,0.005697054,0.0002624164,0.001027388,0.001715643,0.0009812817,0.000519949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001246211,"about_ca_system_score_gemma":0.002266029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02578571,"about_ca_topic_score_gemma":0.04325251,"domain_scores_codex":[0.9971908,0.0005585874,0.0004882308,0.0006689511,0.0005288103,0.0005647805],"domain_scores_gemma":[0.9932219,0.000787893,0.00358948,0.0007995932,0.000968226,0.0006329678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001851551,0.00003141362,0.9965479,0.00004501841,0.0002684532,0.00004053506,0.00004678455,0.00007883476,0.00006956911,0.00006205836,0.001229177,0.001395099],"study_design_scores_gemma":[0.00002943303,0.0001114544,0.9971302,0.00006351196,0.0002378438,0.0001769576,0.0002971599,0.0003456215,0.00006252777,0.00003316675,0.001497623,0.00001444756],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9563898,0.00106863,0.0004345862,0.0002103641,0.00003344573,0.0001125412,0.03876286,0.00003381652,0.002954031],"genre_scores_gemma":[0.9745326,0.0005622811,0.0003529144,0.0001685409,0.00003933905,0.0001227735,0.02366333,0.00002316466,0.0005350302],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02578571,"threshold_uncertainty_score":0.05127126,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1449301328231594,"score_gpt":0.4632121752870974,"score_spread":0.318282042463938,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}